AKT1 and ischemia: Considering that ARRB2 has been shown to inhibit the apoptosis of hepatocytes and promote their proliferation in mice suffering from hepatic ischemia reperfusion, our results suggested that ARRB2 may protects mice against hepatic IRI by activating PI3K/Akt signaling.